Cargando…

Whole-Body Functional MRI and PET/MRI in Multiple Myeloma

SIMPLE SUMMARY: Whole-body magnetic resonance imaging (MRI) is recognized as the most sensitive imaging technique for the detection of bone marrow infiltration, and was therefore, recently included in the new diagnostic myeloma criteria, as proposed by the International Myeloma Working Group. The us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulé, Sébastien, Reizine, Edouard, Blanc-Durand, Paul, Baranes, Laurence, Zerbib, Pierre, Burns, Robert, Nouri, Refaat, Itti, Emmanuel, Luciani, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693006/ https://www.ncbi.nlm.nih.gov/pubmed/33121132 http://dx.doi.org/10.3390/cancers12113155

Ejemplares similares

Whole body MRI and PET/CT in haematological malignancies
por: Lin, Chieh, et al.
Publicado: (2007)

Impact of the (18)F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients
por: Vermersch, Mathilde, et al.
Publicado: (2021)

MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
por: Rahmouni, Alain, et al.
Publicado: (2005)

Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation
por: Boussouar, Samia, et al.
Publicado: (2016)

Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations
por: Rahmouni, Alain, et al.
Publicado: (2014)

Abdominal imaging in ICU patients with viral pneumonia: Are findings in COVID-19 patients really different from those observed with non-SARS-CoV-2 viral pneumonia?
por: Reizine, Edouard, et al.
Publicado: (2022)

Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma
por: Lin, Chieh, et al.
Publicado: (2012)

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma
por: Westerland, Olwen, et al.
Publicado: (2021)

Whole body diffusion weighted MRI – a new view of myeloma
por: Messiou, Christina, et al.
Publicado: (2015)

Inter-observer agreement of baseline whole body MRI in multiple myeloma
por: Croft, James, et al.
Publicado: (2020)

Whole-body MRI and diffusion MRI
por: Padhani, Anwar R
Publicado: (2014)

Quantitative CT analysis for assessing response in lymphoma (Cheson’s criteria): Wednesday 5 October 2005, 08:30–10:00
por: Rahmouni, Alain, et al.
Publicado: (2005)

Whole body MRI in multiple myeloma: Optimising image acquisition and read times
por: Singh, Saurabh, et al.
Publicado: (2020)

Rapid Whole-Body FDG PET/MRI in Oncology Patients: Utility of Combining Bayesian Penalised Likelihood PET Reconstruction and Abbreviated MRI
por: Inukai, Junko Inoue, et al.
Publicado: (2023)

MRI and PET of bone marrow in lymphoproliferative diseases
por: Rahmouni, A., et al.
Publicado: (2015)

([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
por: Gallais Sérézal, I., et al.
Publicado: (2021)

Whole-body diffusion-weighted imaging in lymphoma
por: Lin, C., et al.
Publicado: (2010)

Motion Correction of Whole-Body PET Data with a Joint PET-MRI Registration Functional
por: Fieseler, Michael, et al.
Publicado: (2014)

The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma
por: Rowland, James, et al.
Publicado: (2020)

Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI
por: Takasu, Miyuki, et al.
Publicado: (2020)

Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors
por: Carlbom, Lina, et al.
Publicado: (2017)

Automatic lesion detection and segmentation of (18)F-FET PET in gliomas: A full 3D U-Net convolutional neural network study
por: Blanc-Durand, Paul, et al.
Publicado: (2018)

Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant
por: Mesguich, Charles, et al.
Publicado: (2021)

MRI and PET/MRI in hematologic malignancies
por: Mayerhoefer, Marius E., et al.
Publicado: (2019)

Whole-body simultaneous time-of-flight PET-MRI: early experience with clinical studies
por: Minamimoto, Ryogo, et al.
Publicado: (2015)

(18)F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
por: Baratto, Lucia, et al.
Publicado: (2018)

A deep learning-based whole-body solution for PET/MRI attenuation correction
por: Ahangari, Sahar, et al.
Publicado: (2022)

Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma
por: Ahmed, Naeem, et al.
Publicado: (2019)

Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study
por: Bray, Timothy J. P., et al.
Publicado: (2017)

Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI
por: Zambello, Renato, et al.
Publicado: (2018)

P918: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MRI FOR STAGING PATIENTS IN HIGH RISK SMOLDERING MYELOMA: A PROSPECTIVE TRIAL
por: Cerchione, Claudio, et al.
Publicado: (2023)

Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)

Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study
por: Mulé, Sébastien, et al.
Publicado: (2023)

Prospective evaluation of whole-body MRI and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2020)

Markerless motion tracking and correction for PET, MRI, and simultaneous PET/MRI
por: Slipsager, Jakob M., et al.
Publicado: (2019)

MRI and amino acid PET detection of whole-brain tumor burden
por: Chen, Peng, et al.
Publicado: (2023)

P953: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MRI FOR STAGING NEWLY DIAGNOSED AND RELAPSED/REFRACTORY MULTIPLE MYELOMA: A PROSPECTIVE TRIAL
por: Cerchione, Claudio, et al.
Publicado: (2023)

Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review
por: Ciliberto, Mario, et al.
Publicado: (2013)

Impact of PET acquisition durations on image quality and lesion detectability in whole-body (68)Ga-PSMA PET-MRI
por: Noto, Benjamin, et al.
Publicado: (2017)

Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma
por: Otero, S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uu098uu6bvr6jvu7sniq49b21n